Introduction
============

Microtubule-associated proteins (MAPs)[\*](#fn1){ref-type="fn"} a group of filamentous proteins copurified with tubulin through repetitive cycles of depolymerization and reassembly, have been demonstrated to promote assembly of tubulin, bind and stabilize microtubules (MTs), and form cross-bridge structures between MTs. They are considered to play an important role in neuronal morphogenesis (for review see [@bib19], [@bib20]). Diversities of MAPs are expressed in both the central and peripheral nervous systems (CNS and PNS, respectively). MAP1B (also known as MAP1.2, MAP1x, or MAP5) and MAP2 are among the most abundant neuronal MAPs. Both proteins are expressed in a developmentally regulated manner. MAP1B is expressed prominently during early stages of neuronal development (for review see [@bib47]); in contrast, MAP2 is present at both early and late stages. MAP2 has three isoforms, MAP2A, B, and C. MAP2C is localized in cell bodies, dendrites, and axons of juvenile neurons, whereas MAP2A and B are localized mainly in dendrites of mature neurons (for review see [@bib33]).

Several efforts have been made to elucidate the functions of MAPs in vivo by analyzing a series of knockout mice. Analysis of *tau* knockout mice revealed a decrease in the number of MTs in small caliber axons; however, they have extended axons indistinguishable from those of wild-type controls ([@bib18]). MAP1B-deficient mice have shown an abnormal brain architecture including delayed myelination, reduced axon caliber, tract malformation, and layer disorganization ([@bib9]; [@bib40], [@bib41]; [@bib15]; [@bib24]). On the other hand, phenotypes analysis of MAP2-deficient mice has never been reported.

In this study, we present data of MAP2-deficient (*map*2^−/^−) mice that showed a normal cytoarchitecture of their nervous system. We considered that MAP1B may share functions with MAP2 and could compensate for the loss of MAP2 based on the following reasons. (a) They are colocalized in both axons and dendrites, particularly in developing neurons, whereas in later stages MAP2 is localized mainly in dendrites ([@bib19], [@bib20]). They form cross-bridge structures between MTs ([@bib35]; [@bib19]; [@bib20]). In the case of Tau and MAP2, they were suggested to determine the MT spacing in axons and dendrites, respectively ([@bib6]). (b) Studies using an in vitro culture system suggest that MAP2 and MAP1B have similar functions in neuronal morphogenesis. Attenuation of expression of either MAP1B expression in PC12 cells ([@bib3]) or casein kinase II, which catalyzes a site-specific phosphorylation of MAP1B ([@bib48]) in neuroblastoma cells by antisense oligodeoxynucleotides has indicated the inhibition of neuritogenesis. Suppression of MAP2 expression in cultured cerebellar macroneurons ([@bib4]) or in rat cortical neurons ([@bib36]) has also indicated the inhibition of neurite outgrowth concomitant with disorganized MTs. (c) MAP2 and MAP1B are similar in their effects on MT dynamics and organization in vitro. Both of them can promote tubulin assembly and bind and stabilize MTs ([@bib20]; [@bib44]). (d) In the case of axonal elongation, Tau and MAP1B have overlapping functions in MT organization, particularly in their neuronal growth cones ([@bib41]; [@bib11]).

With these as a background, we generated mice with disrupted *map2* and *map1b* genes to study the possible synergistic functions of MAP2 and MAP1B in vivo. The loss of MAP2 and MAP1B in mice leads to perinatal lethality. Our findings are summarized as follows. (a) There were striking abnormalities in their cortical and subcortical cytoarchitectures. Neuronal birth-dating analyses revealed a significant retardation in neuronal migration. The packing order of cortical neurons in *map2* ^−/^−*map1b* ^−/^− mice was in an "inside-out" pattern, which is different from that of *reeler* mice. (b) There was suppression of axonal and dendritic elongation and microtubule bundling in cultured neurons from the mutant mice. Synergistic effects caused by the loss of MAP2 and MAP1B were more apparent in dendrites than in axons. (c) Distances between MTs were reduced markedly in both axons and dendrites. This study demonstrated clearly that MAP2 and MAP1B cooperatively play significant functions for both axonal and dendritic morphogenesis, whereas their roles in dendritic morphogenesis are more dominant.

Results
=======

MAP2 is not essential for mouse survival
----------------------------------------

A gene-targeting vector with a neo cassette inserted into the exon coding the first MT-binding repeat of MAP2 was constructed. The location of neo insertion is indicated by an arrow in [Fig. 1](#fig1){ref-type="fig"} A. The disrupted exon corresponds to exon 15 of the human *map2* gene ([@bib23]). The vector was electroporated into embryonic stem cells, and homologous recombinant clones were isolated. Germline chimeras were established and mice, heterozygous (*map*2^+/^−) and homozygous (*map*2^−/^−) for the mutated *map2* gene, were produced by a conventional gene-targeting method ([@bib18]). They were viable, fertile, and grew without any lethalities. They appeared healthy in their normal cage environment. To examine the effects of the mutation introduced into the *map2* gene, we analyzed the expression of MAP2 in the brains of the *map*2^−/^− mice by Western blotting. The complete loss of MAP2 immunoreactivities in the *map*2^−/^− mutant mice was shown clearly by analysis using seven monoclonal antibodies ([Fig. 1, A and B](#fig1){ref-type="fig"}, the location of specific epitopes in MAP2 is shown in [Fig. 1](#fig1){ref-type="fig"} A). No smaller protein corresponding to the NH~2~ terminus of the MAP2 was detected, which suggests that if a truncated protein without MT-binding domain was produced it would be unstable.

![**Targeted disruption of the *map2* gene.** (A) Diagrammatic representation of MAP2 structure. Epitopes of six anti-MAP2 mAbs ([@bib22]) are shown. The neo cassette ([@bib18]) is inserted at the point indicated by an arrow. (B) Western blotting of crude extracts of the whole brain with a series of anti-MAP2 mAbs (HM2, AP-14, AP-18, AP-21, AP-22, AP-24, and AP-25). Mice at 8 w old were analyzed. Note the absence of MAP2 immunoreactivity in all *map2* ^−/^− lanes. (C) Immunoblot analysis of crude extracts from P0 mouse brain with the anti-MAP2 mAb HM2 and the anti-MAP1B antiserum 3d2. (D) Appearance of *map2* ^+/+^ *map1b* ^+/+^, *map2* ^−/^−*map1b* ^+/+^, *map2* ^+/+^ *map1b* ^−/^−, and *map2* ^−/^−*map1b* ^−/^− mice at P0.](0106025f1){#fig1}

Next, we performed Western blotting of crude extracts from mouse brains at postnatal day (P)0 to examine the juvenile isoform, MAP2C. MAP2C immunoreactivity was also absent in the juvenile *map*2^−/^− mutant ([Fig. 1](#fig1){ref-type="fig"} C).

Thus, all three isoforms of MAP2 (MAP2A, B, and C) were absent in the crude extracts from *map*2^−/^− mouse brains at P0 ([Fig. 1](#fig1){ref-type="fig"} C), and the mutation introduced into the murine *map2* gene abolishes all expression of MAP2. From these results, it appears that MAP2 is not essential for basic neuronal development.

Perinatal lethality in *map2* ^−^ **^/^**−*map1b* ^−^ **^/^**− mice
-------------------------------------------------------------------

We hypothesized that some other neuronal MAPs could compensate for the lack of MAP2 and that the candidate is MAP1B based on reasons summarized in the introduction. To test this hypothesis, double homozygous mice with disrupted *map2* and *map1b* genes (*map2* ^−/^−*map1b* ^−/^−) were generated by intercrossing *map2* ^+/^−*map1b* ^+/^− double heterozygous mice, which were obtained by crossing a *map2* ^−/^− mouse line with a *map1b* ^−/^− mouse line ([@bib40]). *Map2* ^+/^−*map1b* ^+/^− mice developed normally and are indistinguishable from *map2* ^+/+^ *map1b* ^+/+^mice. *Map2* ^−/^− *map1b* ^−/^− mice could not survive beyond P0, whereas both *map2* ^−/^−, *map1b* ^+/+^, and *map2* ^+/+^ *map1b* ^−/^− mice were viable at this stage ([@bib40], [@bib41]). There was no significant difference in the body size between *map2* ^−/^− *map1b* ^−/^− mice and mice of other genotypes ([Fig. 1](#fig1){ref-type="fig"} D). MAP2 could not be detected in brain lysates derived from *map*2^−/^−*map1b* ^−/^− mice, whereas anti-MAP1B antibodies very faintly stained a band of protein in brain lysates from *map*2^+/+^ *map1b* ^−/^− and *map*2^−/^−*map1b* ^−/^− mice ([Fig. 1](#fig1){ref-type="fig"} C). This faint immunoreactivity is suggested to be derived from a minor transcript, encoding an NH~2~ terminally truncated MAP1B ([@bib40]), which might render the phenotypes of the *map1b* ^−/^− mice more moderate than those of a newly reported *map1b* mutant (MAP1BΔ93), which have a complete deletion of the *map1b* gene ([@bib24]).

Unique neuropathological findings in *map2* ^−^ **^/^**−*map1b* ^−^ **^/^**− mice
---------------------------------------------------------------------------------

The dominant expressions of MAP2 and MAP1B in the brain were suggestive of possible neuronal dysfunction in *map2* ^−/^−*map1b* ^−/^− mice. Histopathological analysis of the brain sections revealed abnormalities in the layer formation and the positioning of neurons in the brains of *map2* ^−/^− *map1b* ^−/^− mice ([Fig. 2](#fig2){ref-type="fig"}). Normal stratification of neocortical neurons was not observed in their cerebral cortex where the molecular layer was thinner than that of *map2* ^+/+^ *map1b* ^+/+^ mice, the supra-/infragranular parts were unclear, and the subplate was diffuse ([Fig. 2](#fig2){ref-type="fig"} D). The hippocampus was affected also, showing a dispersed arrangement of cell layers ([Fig. 2](#fig2){ref-type="fig"} H). Many other parts of the brain, including the olfactory bulb and cerebellum, exhibited disrupted laminar structures (unpublished data). The inferior olivary complex showed an abnormal folding similar to that of *reeler* mice ([Fig. 2](#fig2){ref-type="fig"} L) ([@bib14]). Inordinate separation of the basilar pons cells was also observed ([Fig. 2](#fig2){ref-type="fig"} P, arrows). On the other hand, *map2* ^−/^−*map1b* ^+/+^ mice ([Fig. 2, B, F, J, and N](#fig2){ref-type="fig"}) showed no apparent abnormalities in the layer formation compared with *map2* ^+/+^ *map1b* ^+/+^ mice ([Fig. 2, A, E, I, and M](#fig2){ref-type="fig"}). The brains of *map2* ^+/+^ *map1b* ^−/^− mice did show defects in laminar formation ([Fig. 2, C, G, K, and O](#fig2){ref-type="fig"}), which were similar to but not as drastic as those observed in *map2* ^−/^− *map1b* ^−/^− brains ([PFig. 2, D, H, L, and P](#fig2){ref-type="fig"}).

![**Histopathology of the brain.** Bodian-stained paraffin-embedded coronal sections of brains of *map2* ^+/+^ *map1b* ^+/+^, *map2* ^−/^−*map1b* ^+/+^, *map2* ^+/+^ *map1b* ^−/^−, and *map2* ^−/^−*map1b* ^−/^− mice at P0. (A--D) Cerebral cortex. The cortical layering is disrupted in *map2* ^−/^−*map1b* ^−/^− mice. CC, corpus callosum; CPi, infragranular part; CPs, supragranular parts; ML, molecular layer; SP, subplate. (E--H) Hippocampus. Note the dispersed arrangement of pyramidal cells in *map2* ^−/^−*map1b* ^−/^− mice. CA1, CA1 field; CA3, CA3 field; DG, dentate gyrus; LAC-MOL, lacunosum and molecule; STR.OR, stratum oriens; STR.PYR, stratum pyramidale; STR.RAD, strata radiatum. (I--L) The inferior olivary complex. Abnormal fold-ing was observed in *map2* ^+/+^ *map1b* ^−/^− (K) and *map2* ^−/^−*map1b* ^−/^− mice (L). DAO, dorsal accessory olive; MAO, medial accessory olive; PO, principal olive. (M--P) Pons. The nuclei of pons were separated completely at midline in *map2* ^−/^−*map1b* ^−/^− mice (P, arrows).](0106025f2){#fig2}

Fiber tract malformation was another striking abnormality in the brains of *map2* ^+/+^ *map1b* ^−/^− and *map2* ^−/^−*map1b* ^−/^− mice ([Fig. 3](#fig3){ref-type="fig"}). In the brains of *map2* ^−/^−*map1b* ^−/^− mice, the corpus callosum, one of the major telencephalic fiber tracts, was not connected between hemispheres and formed aberrantly oriented fibers ([Fig. 3](#fig3){ref-type="fig"} H, arrowheads) called Probst\'s bundles ([Fig. 3](#fig3){ref-type="fig"} D, Pb) in all of the *map2* ^−/^−*map1b* ^−/^− mice examined (we examined five animals for each genotype). The corpus callosum was formed normally in all *map2* ^+/+^ *map1b* ^+/+^ ([Fig. 3, A and E](#fig3){ref-type="fig"}) and *map2* ^−/^−*map1b* ^+/+^ mice ([Fig. 3, B and F](#fig3){ref-type="fig"}). In *map2* ^+/+^ *map1b* ^−/^− mice, the size of the corpus callosum decreased ([Fig. 3, C and G](#fig3){ref-type="fig"}). The size of the septum pellucidum in *map2* ^−/^−*map1b* ^−/^− mouse brains ([Fig. 3](#fig3){ref-type="fig"} D, asterisk) increased significantly compared with that in *map2* ^+/+^ *map1b* ^+/+^, *map2* ^−/^−*map1b* ^+/+^, and *map2* ^+/+^ *map1b* ^−/^− mouse brains ([Fig. 3](#fig3){ref-type="fig"}, A--C). The lateral ventricles had an abnormal shape in the *map2* ^−/^−*map1b* ^−/^− mouse forebrain ([Fig. 3](#fig3){ref-type="fig"} D, arrowheads), possibly under the pressure of Probst\'s bundles. Other fiber tracts such as the anterior commissure ([Fig. 3](#fig3){ref-type="fig"} D, arrows) and pyramidal tract (unpublished data) were also hypoplastic in *map2* ^−/^−*map1b* ^−/^− mice. These defects in fiber tracts were also observed in the brains of *map2* ^+/+^ *map1b* ^−/^− mice ([Fig. 3, C and G](#fig3){ref-type="fig"}), although the severity of the defects was significantly greater in the brains of *map2* ^−/^−*map1b* ^−/^− mice ([Fig. 3, D and H](#fig3){ref-type="fig"}) than those of *map2* ^+/+^ *map1b* ^−/^− mice. The brains of *map2* ^−/^−*map1b* ^+/+^ mice showed normal tracts ([Fig. 3, B and F](#fig3){ref-type="fig"}). Next, we measured the size of the anterior commissure to compare the axon tract development of each genotype quantitatively ([Fig. 3](#fig3){ref-type="fig"} I). The size of the anterior commissure in the brains of *map2* ^−/^−*map1b* ^+/+^ mice did not differ from that of *map2* ^+/+^ *map1b* ^+/+^ mice (*P* \> 0.05, post hoc test), whereas this decreased in the brains of *map2* ^+/+^ *map1b* ^−/^− (*P* \< 0.05) and *map2* ^−/^−*map1b* ^−/^− mice (*P* \< 0.01) compared with that of *map2* ^+/+^ *map1b* ^+/+^ mice. The anterior commissure in the brains of *map2* ^−/^−*map1b* ^−/^− mice is significantly smaller than that of *map2* ^+/+^ *map1b* ^−/^− mice (*P* \< 0.05).

![**Abnormalities in fiber tract formation in *map2*** ^−^ **^/^**− ***map1b*** ^−^ **^/^**−**mice.** (A--H) Bodian-stained sections of brains of *map2* ^+/+^ *map1b* ^+/+^, *map2* ^−/^−*map1b* ^+/+^, *map2* ^+/+^ *map1b* ^−/^−, and *map2* ^−/^−*map1b* ^−/^− mice at P0. (A--D) Coronal sections of cerebrum. Note the disconnection of the corpus callosum with the formation of Probst\'s bundle in *map2* ^−/^−*map1b* ^−/^− mice (D). The anterior commissure is indicated by arrows. Asterisk indicates the enlarged septum pellucidum, and arrowheads indicate abnormally shaped lateral ventricles in *map2* ^−/^−*map1b* ^−/^− mice (D). AC, anterior commissure; CC, corpus callosum; LV, lateral ventricle; Pb, Probst\'s bundles; S, septum; SEP, septum pellucidum; St, striatum. (E--H) Sagittal views of the corpus callosum. The *map2* ^−/^−*map1b* ^−/^− mice present aberrantly oriented fiber of the corpus callosum (H, arrowhead). (I) Comparison of anterior commissure size. Coronal sectional areas of anterior commissure at P0 were compared. Each bar represents the mean ± SD of five mice for each genotype. \**P* \< 0.05; \*\**P* \< 0.01 (post hoc test).](0106025f3){#fig3}

These findings raised the following two questions. First, were the abnormalities in axon tract formation primarily due to the defect in neurite outgrowth or secondary to the abnormal positioning of neurons? Second, was the axon tract malformation restricted to CNS or common in both CNS and PNS? To answer these issues, we examined the neurites of embryonic PNS by immunostaining whole embryos at embryonic day (E)12 using the monoclonal neurofilament antibody 2H3 ([Fig. 4](#fig4){ref-type="fig"}). The outgrowth of spinal nerves was markedly retarded in *map2* ^−/^−*map1b* ^−/^− embryos without aberrant positioning of the neuronal cell bodies ([Fig. 4](#fig4){ref-type="fig"} D, arrows). Nerve fibers were also fasciculated normally in these embryos. Thus, it was concluded that retarded neurite outgrowth is not due to the perturbed neuronal migration. That is, both neuronal migration and neurite outgrowth are primarily affected by the lack of MAP2 and MAP1B and that both CNS and PNS display defects in neurite outgrowth.

![**Whole-mount immunostaining of E12 embryos using antineurofilament antibodies (2H3).** Impaired outgrowth of spinal nerves in *map2* ^−/^−*map1b* ^−/^− embryos (D, arrows).](0106025f4){#fig4}

Defects in neuronal migration
-----------------------------

To get insights into the pathogenesis of cortical dysgenesis in *map2* ^−/^−*map1b* ^−/^− mice, we first examined the subplate neurons at E17 by immunohistochemistry using the monoclonal antibody, CS56, a marker of subplate neurons ([@bib1]) ([Fig. 5](#fig5){ref-type="fig"}, A--D). The preplate of *map2* ^−/^−*map1b* ^−/^− mice had divided into the subplate and marginal zones, although the subplate cells showed abnormally diffuse cellular architecture ([Fig. 5](#fig5){ref-type="fig"} D, arrows). Next, we performed neuronal birth-dating experiments to get insights into the pathogenesis of cortical dysgenesis ([Fig. 5](#fig5){ref-type="fig"}, E--L). We injected BrdU into pregnant female mice at E12 and E14 and examined brains of their pups at E18. When BrdU was injected at E12, no significant difference was found in the distribution pattern of labeled cells among *map2* ^+/+^ *map1b* ^+/+^, *map2* ^−/^−*map1b* ^+/+^, *map2* ^+/+^ *map1b* ^−/^−, and *map2* ^−/^−*map1b* ^−/^− mice ([Fig. 5](#fig5){ref-type="fig"}, E--H and M) where the majority of positive cells were localized in the deep layer of the cerebral cortex ([Fig. 5](#fig5){ref-type="fig"}, E--H and M, CPi and SP). On the other hand, when BrdU was injected at E14, the distribution pattern of labeled cells in *map2* ^−/^−*map1b* ^−/^− mice was different from that in *map2* ^+/+^ *map1b* ^+/+^, *map2* ^−/^− *map1b* ^+/+^, and *map2* ^+/+^ *map1b* ^−/^− mice ([Fig. 5](#fig5){ref-type="fig"}, I--L and N). In *map2* ^−/^−*map1b* ^−/^− mice, the number of labeled neurons located in the superficial layers ([Fig. 5, L and N](#fig5){ref-type="fig"}, CPs) decreased significantly compared with those in mice of other genotypes ([Figs. 5](#fig5){ref-type="fig"}, I--K and N, CPs). These data indicate that the delay of neuronal migration in the cortex of *map2* ^−/^− *map1b* ^−/^− mice is limited to cells generated at a specific period and that the cortex of *map2* ^−/^−*map1b* ^−/^− mice has a normal inside-out packing order of neurons. That is, neurons generated earlier reside in deeper layers, whereas neurons born later occupy more superficial layers.

![**Retarded neuronal migration in *map2*** *^−^**/**−**map1b**^−^**/**−* **mice.** (A--D) Characterization of the subplate layer at E17. Coronal sections were immunostained with an anti-CSPG antibody (CS56), which is a marker for subplate neurons. Note the dispersed arrangement of the subplate neurons of the *map2* ^−/^−*map1b* ^−/^− mouse cortex (D, arrows). (E--N) Neuronal birth-dating analysis. Pregnant *map2* ^+/^−*map1b* ^+/^− mice were injected with BrdU at E12 and E14. Pups were fixed at E18. Coronal sections of the forebrains. The sections were immunostained with anti-BrdU antibodies and counterstained with nuclear fast red. (E--H) Labeling with BrdU at E12. The distribution pattern of labeled neurons showed no significant difference between mice of different genotypes. (I--L) Labeling at E14. Labeled neurons were observed predominantly in the superficial layers in *map2* ^+/+^ *map1b* ^+/+^ mice (I), whereas many of the labeled neurons remained in the deeper half of the cortex in *map2* ^−/^−*map1b* ^−/^− mice (L). (M and N) Histograms of the E12 (E--H; M) and E14 (I--L; N) birth-dating experiment. Bar shows the distribution of BrdU-labeled neurons in each bin. Lines indicate deep and superficial cortical boundaries. ML, molecular layer; MZ, marginal zone; CPi, infragranular part of cortex; CPs, supragranular part of cortex; SP, subplate layer.](0106025f5){#fig5}

One possible mechanism that explains the retardation in neuronal migration is that the radial glial fibers, which guide postmitotic neurons during their migration, are altered or absent in *map2* ^−/^−*map1b* ^−/^− mice. To examine the radial glial fiber system, E17 cortices were stained with the monoclonal antibody RC2, a marker for radial glial cells ([@bib25]). At E17, the density of radial glial fibers, which ran a course perpendicular to the pial surface, decreased slightly in *map2* ^+/+^ *map1b* ^−/^− and *map2* ^−/^−*map1b* ^−/^− mice, whereas there was no difference in the density of radial glial fibers between *map2* ^−/^−*map1b* ^+/+^ and *map2* ^+/+^ *map1b* ^+/+^ mice (unpublished data). This finding indicates that the structural defect of radial glial fibers in *map2* ^−/^−*map1b* ^−/^− mice could affect their neuronal migration. However, MAP2 and MAP1B were expressed predominantly in neurons but were absent in radial glial fibers as revealed by double immunostaining of the murine cortex with RC2 and anti-MAP2 or anti-MAP1B antibodies at E14 (unpublished data). Taken collectively, it seems that altered radial glial structures are not primary defects. Cortical neurons are affected primarily by the deficiency in MAP2 and MAP1B, and disrupted neuron--glia interaction may be responsible for the glial defect.

Since it is known that the lack of *reelin* results in an abnormal cortical pattern in *reeler* mice, we compared the expression of Reelin between *map2* ^+/+^ *map1b* ^+/+^ and *map2* ^−/^− *map1b* ^−/^− mice by immunohistochemistry to obtain insights into the possible relationship of the mutant mice with the Reelin pathway. However, *map2* ^−/^−*map1b* ^−/^− mice expressed Reelin in their cortical Cajal-Rezius cells, and there was no difference in the staining pattern between the mice of different genotypes (unpublished data).

Impairment of axonal and dendritic elongation of hippocampal neurons with disrupted MT organization
---------------------------------------------------------------------------------------------------

To compare the neurite development of control and mutant mice, cultured hippocampal neurons were analyzed. This culture system enabled us to investigate the polar development of individual neurons maintained separately from glias ([@bib16]). At first, we examined the expression of MAP2 and MAP1B in cultured hippocampal neurons. In *map2* ^+/^−*map1b* ^+/+^ mouse neurons cultured for 2 d, MAP2 and MAP1B were expressed abundantly in axons and minor processes including their growth cones (unpublished data) as reported previously ([@bib2]; [@bib7]). The majority of *map2* ^+/^−*map1b* ^+/+^ neurons cultured for 3 d developed a single axon and several minor processes ([Fig. 6](#fig6){ref-type="fig"} A). They were classified as neurons at stage 3 of development ([@bib16]). Neurons from *map2* ^−/^− *map1b* ^+/+^, *map2* ^+/^−*map1b* ^−/^−, and *map2* ^−/^−*map1b* ^−/^− mice were also polarized. *Map2* ^+/^−*map1b* ^+/+^ and *map2* ^−/^− *map1b* ^+/+^ mouse neurons did not differ in their lengths of axon and dendritic minor processes (*P* \> 0.05, post hoc test) ([Fig. 6, A and B](#fig6){ref-type="fig"}, and [Table I](#tbl1){ref-type="table"}). However, the neurite lengths of *map2* ^+/^−*map1b* ^−/^− and *map2* ^−/^−*map1b* ^−/^− mouse neurons ([Fig. 6, C and D](#fig6){ref-type="fig"}) decreased significantly compared with those of *map2* ^+/^−*map1b* ^+/+^ mouse neurons (*P* \< 0.01) ([Table I](#tbl1){ref-type="table"}). We compared the neurite lengths between *map2* ^+/^−*map1b* ^−/^− and *map2* ^−/^−*map1b* ^−/^− mouse neurons. The lengths of minor processes of *map2* ^−/^− *map1b* ^−/^− mouse neurons were significantly shorter than those of *map2* ^+/^−*map1b* ^−/^− ones (*P* \< 0.05), whereas the length of axons did not differ between the two mouse genotypes (*P* \> 0.05) ([Fig. 6, C and D](#fig6){ref-type="fig"}, and [Table I](#tbl1){ref-type="table"}). Taken together, *map2* and *map1b* mutations have cell autonomous effects on neurite outgrowth, which is more synergistic in dendritic minor processes than in axonal ones. After 18 d of culture, the difference in the dendritic length between *map2* ^−/^−*map1b* ^−/^− and the control or single knockout mouse neurons becomes more apparent as shown in [Fig. 6, E--H](#fig6){ref-type="fig"}. In these figures, dendrites are visualized by immunostaining using an anti-GluR1 antibody.

![**Phenotypes of cultured hippocampal pyramidal neurons.** (A--D) Representative hippocampal neurons after 3 d of culture. Phase--contrast micrographs of neurons obtained from *map2* ^+/^−*map1b* ^+/+^ (A, control), *map2* ^−/^−*map1b* ^+/+^ (B), *map2* ^+/^−*map1b* ^−/^− (C), and *map2* ^−/^−*map1b* ^−/^− (D) mice. (E--H) Dendrites are visualized by immunostaining of neurons cultured for 18 d using an anti-GluR1 antibody. The lengths of dendrites of *map2* ^−/^−*map1b* ^−/^− neurons (H) were significantly shorter than those of neurons of other genotypes (E--G).](0106025f6){#fig6}

###### Quantitative comparison of neurite development in cultured hippocampal neurons

  Neurite length after 3 d in culture                                   
  ------------------------------------- ----------- --- --------------- ---
  Genotype *map2map1b*                  Axon            Minor process   
                                        Mean ± SD   n   Mean ± SD       n
                                        μm              μm              

Significantly different from *map2^−/−^map1b^−/−^* mice at *P* \< 0.01 using the post hoc test. Values based on three independent experiments. *n*, number of neurites examined.

Rescue of MAP1B deficiency by MAP2C
-----------------------------------

We performed a rescue experiment to confirm if MAP2 and MAP1B have overlapping functions in neurite development. An adenoviral vector encoding EGFP-tagged MAP2C was used for the expression of MAP2C in cultured hippocampal neurons, and the lengths of axons were quantitated. In the coverslips exposed to the viral vector, \>95% of neurons were GFP-positive ([Fig. 7](#fig7){ref-type="fig"}, E--H). The axonal lengths of *map2* ^+/^−*map1b* ^−/^− and *map2* ^−/^−*map1b* ^−/^− mouse neurons expressing exogenous MAP2C were increased compared with those of noninfected neurons (*P* \< 0.05, post hoc test) ([Fig. 7, C, D, G, H, and I](#fig7){ref-type="fig"}). On the other hand, there was no statistical difference in the axonal length between noninfected and infected neurons in the experiment using *map2* ^−/^− *map1b* ^+/^− mouse neurons ([Fig. 7](#fig7){ref-type="fig"} I). This indicates that the effect of exogenous MAP2C expression on the MAP2 deficiency is negligible in this rescue experiment because the axonal defect caused by MAP2 deficiency was rather subtle and that the enhanced axonal growth observed in *map2* ^+/^− *map1b* ^−/^− and *map2* ^−/^−*map1b* ^−/^− mouse neurons was mainly a result from a rescue of MAP1B deficiency. Taken collectively, the function of MAP1B could be partially complemented by MAP2C, suggesting that MAP2 and MAP1B have an overlapping function.

![**Rescue experiments.** (A--D) Noninfected control cultured hippocampal neurons of each genotype. (E--H) Neurons cultured for 3 d after infection with adenoviral vectors encoding EGFP-tagged MAP2C. Green color indicates neurons expressing MAP2C. (I) Quantification of the axonal length. In *map2* ^+/^−*map1b* ^−/^− and *map2* ^−/^−*map1b* ^−/^− mouse neurons after infected with adenoviral vectors, the lengths of axons of infected neurons were significantly longer than those of noninfected controls. Each bar represents the mean ± SD of at least 60 neurons for each genotype. \**P* \< 0.05 (post hoc test).](0106025f7){#fig7}

Disorganized MTs in growth cones
--------------------------------

Next, we examined the cytoskeletal organization of cultured neurons to get insights into the cellular pathophysiology underlying the defects in neurite elongation. We focused on the growth cones because they are a key element for a neuron to extend its axons and dendrites. We double labeled cells cultured for 2 or 8 d with an antityrosinated α-tubulin antibody and FITC-phalloidin ([Fig. 8](#fig8){ref-type="fig"}) and observed their growth cones. In the majority of growth cones of *map2* ^+/^− *map1b* ^+/+^ mouse neurons, MTs were bundled together into tight arrays around the central region, which was surrounded by a radially oriented array of F-actin ([Figs. 8, A, N, and O](#fig8){ref-type="fig"}). In contrast, MTs of the neurons from *map2* ^−/^− *map1b* ^−/^− mice were dispersed frequently with or without loops ([Fig. 8, H and L](#fig8){ref-type="fig"}) throughout the growth cone with a less tendency to form bundles ([Fig. 8, N and O](#fig8){ref-type="fig"}). These growth cones with dispersed MTs exhibited an unusually large size where the mass of MTs often formed a disorganized network ([Fig. 8](#fig8){ref-type="fig"} M).

![**Morphology of growth cones in cultured hippocampal pyramidal neurons.** (A--M) Cells were double labeled with phalloidin (green) and a monoclonal antibody against tyrosine tubulin TUB-1A2 (red). Examples of bundled (A--D), spread (E-H), and looped (I-L) MTs in the growth cones after 2 d of culture of neurons from each genotype are shown. (M) Example of the abnormal cytoskeletal mass of growth cones from 8-d-old cultured neurons of *map2* ^−/^−*map1b* ^−/^− mice. (N and O) Histograms of the percentages of three types of MT organization of the growth cones in axons (N) and minor processes (O).](0106025f8){#fig8}

Altered MT spacing in vitro and in vivo
---------------------------------------

We performed electron microscopic analysis to examine the possible MT change in the neuritic shafts of cultured neurons because immunofluorescence microscopy does not have sufficient resolution for discriminating a single MT in them. In neuritic shafts of *map2* ^+/^−*map1b* ^+/^− mouse neurons, MT polymers ran parallel to each other, and the spacing between MTs was maintained appropriately by cross-bridges of MAPs ([Fig. 9](#fig9){ref-type="fig"} A). However, the MT spacing was disrupted in neurons from *map2* ^−/^−*map1b* ^−/^− mice where MTs often become closer to, and contacted each other at their sides ([Fig. 9](#fig9){ref-type="fig"} B, arrows).

![**Decreased spacing between MTs in *map2*** ^−^ **^/^**− ***map1b*** ^−^ **^/^**− **mice.** (A and B) Electron micrographs of neuritic shafts of cultured hippocampal neurons from control (*map2* ^+/^−*map1b* ^+/^−) and *map2* ^−/^−*map1b* ^−/^− mice. MT spacing decreased with many contacting MTs in *map2* ^−/^−*map1b* ^−/^− mouse neurons (B, arrows). (C--J) Cross section of the callosal axons (C--F) and CA1 region of the hippocampal pyramidal cell dendrites (G--J) at P0. (K and L) Compilation of wall-to-wall distances between the nearest adjacent MTs in corpus callosum axons (K) and CA1 region of the hippocampal pyramidal cell dendrites (L). *n* = 496 (*map2* ^+/+^ *map1b* ^+/+^), *n* = 570 (*map2* ^−/^−*map1b* ^+/+^), *n* = 548 (*map2* ^+/+^ *map1b* ^−/^−), and *n* = 623 (*map2* ^−/^−*map1b* ^−/^−) for K; *n* = 492 (*map2* ^+/+^ *map1b* ^+/+^), *n* = 387 (*map2* ^−/^− *map1b* ^+/+^), *n* = 426 (*map2* ^+/+^ *map1b* ^−/^−), and *n* = 272 (*map2* ^−/^−*map1b* ^−/^−) for L.](0106025f9){#fig9}

The altered MT organization observed in cultured cells led us to investigate the possible change in the organization of MTs in vivo in neurons from *map2* ^−/^−*map1b* ^−/^− mice. The axons of corpus callosum ([Fig. 9](#fig9){ref-type="fig"}, C--F) and dendrites of hippocampal pyramidal neurons in the CA1 field ([Fig. 9](#fig9){ref-type="fig"}, G--J) were examined by electron microscopy. We measured the average wall-to-wall distances between the nearest MTs. In the corpus callosum, the average distances were 38.3 ± 12.2 nm (mean ± standard deviation, *n* = 496) for *map2* ^+/+^ *map1b* ^+/+^ mice, 36.5 ± 12.5 nm (*n* = 570) for *map2* ^−/^− *map1b* ^+/+^ mice, 24.2 ± 11.9 nm (*n* = 5, *map2* ^−/^−*map1b* ^−/^− 48) for *map2* ^+/+^ *map1b* ^−/^− mice, and 24.7 ± 11.3 nm (*n* = 623) for *map2* ^−/^−*map1b* ^−/^− mice. A significant difference in the distance was observed between *map2* ^−/^−*map1b* ^−/^− and *map2* ^+/+^ *map1b* ^+/+^ mice (*P* \< 0.01, post hoc test); however, there was no difference between *map2* ^+/+^ *map1b* ^+/+^ and *map2* ^−/^−*map1b* ^+/+^ mice and between *map2* ^+/+^ *map1b* ^−/^− and *map2* ^−/^−*map1b* ^−/^− mice (*P* \> 0.05). The histogram of the spacing between axonal MTs showed a leftward shift for neurons from *map2* ^+/+^ *map1b* ^−/^− and *map2* ^−/^−*map1b* ^−/^− mice ([Fig. 9](#fig9){ref-type="fig"} K). On the other hand, the distances between MTs in the pyramidal cell dendrites showed a significant leftward shift only for neurons from *map2* ^−/^−*map1b* ^−/^− mice but not for those from *map2* ^+/+^ *map1b* ^−/^− mice ([Fig. 9](#fig9){ref-type="fig"} L). From these data, we deduced that the loss of MAP2 and MAP1B reduced MT spacing in axons and dendrites but more synergistically in dendrites.

Normal vesicle transport
------------------------

Because neuronal MTs serve as tracks for the membrane organelle transport process, it is possible that the altered MT spacing in neuritic shafts impairs fast axonal transport, resulting in defects in neuritic outgrowth. To test this possibility, we examined vesicle transport in living hippocampal neurons. Vesicles were visualized by infection with recombinant adenoviruses expressing the GAP-43--green fluorescent protein (GFP) fusion protein ([@bib26]). GAP-43 is a protein that is transported to axons and localized at nerve terminals ([@bib38]). In both control (*map2* ^+/^ *map1b* ^+/^) and *map2* ^−/^−*map1b* ^−/^− mouse neurons, the GAP-43--GFP fusion protein was targeted and localized to the neurites and growth cones ([Fig. 10, A and B](#fig10){ref-type="fig"}, arrows). In the axons, tubular or spherical vesicles were observed to move along the axons in both control and *map2* ^−/^−*map1b* ^−/^− mouse neurons ([Fig. 10, C and D](#fig10){ref-type="fig"}, arrowheads). No apparent difference was observed in the movement of vesicles between the genotypes. We measured the speed of the vesicles for quantitative comparison. There was no significant difference in the mean vesicle speed between the genotypes (*P* \> 0.05, Student\'s *t* test). The average speed of vesicles in the control is 0.63 ± 0.06 Ìm (mean ± standard deviation), whereas the average speed in *map2* ^−/^−*map1b* ^−/^− mouse neurons is 0.59 ± 0.07 Ìm (from three independent experiments, 69--194 vesicles per experiment were analyzed). This data suggests that the vesicle transport is maintained in spite of the altered MT spacing in neuritic shafts.

![**Transport of vesicles containing GAP-43--GFP fusion protein in 18-d-old cultured hippocampal neurons.** Neurons were infected with adenovirus vectors carrying GAP-43--GFP chimeric DNA and observed by confocal laser scan microscopy. (A and B) Expression of GAP-43--GFP fusion protein in 18-d-old cultured hippocampal neurons. Growth cones of axons (arrows) of both control and *map2* ^−/^−*map1b* ^−/^− mouse neurons were stained brightly with GAP-43--GFP. (C and D) GAP-43--GFP--containing vesicles are transported along the axon. The interval between frames is 5 s. Arrowheads indicate the vesicle movement.](0106025f10){#fig10}

Discussion
==========

MAP2 and MAP1B act cooperatively in neuronal development
--------------------------------------------------------

The absence of both MAP2 and MAP1B leads to perinatal lethality, which is far more severe than the phenotypes observed in mice lacking Tau and MAP1B ([@bib41]). *map2* ^−/^−*map1b* ^−/^− mice exhibited a distinctive phenotype with multiple malformations including layer disorganization and tract dysgenesis in both CNS and PNS. These data, combined with the rescue experiment using hippocampal cultures indicates that MAP2 and MAP1B have overlapping functions in neuronal development. These results are also consistent with the fact that MAP2 and MAP1B are among the most abundant MAPs and are coexpressed in the developing nervous system ([@bib47]; [@bib19], [@bib20]). Our detailed analysis of cultured neurons derived from the mutant mice suggests that MAP2 and MAP1B act more synergistically in dendritic outgrowth. In the case of *tau* and *map1b* double knockout mice, synergistic effects were observed in axonal development but not in dendritic development, which is a clear contrast to the case of *map2* ^−/^− *map1b* ^−/^− mice ([@bib41]). Based on these data, it is considered that the pair of MAP2 and MAP1B acts synergistically in dendritic outgrowth and that of tau and MAP1B in axonal outgrowth. These differences could be explained by the finding that Tau and MAP2 are expressed in different compartments of neurons as mentioned in the Introduction.

Role of MAP2 and MAP1B in neuronal migration
--------------------------------------------

Lines of genetic evidence suggest that MTs play central roles in neuronal migration, a critical event in the development of the nervous system. X-linked disease lissencephaly and Miller Dieker lissencephaly caused by *doublecortin* (des [@bib8]; [@bib12]) and *Lis1* ([@bib32]) gene mutations, respectively, are a result of abnormal neuronal migration. Doublecortin has been identified as a novel MAP ([@bib10]; [@bib13]), and LIS1 functions as an unconventional MAP ([@bib34]; [@bib21]). Furthermore, two classic MAPs, Tau and MAP1B, are also involved in neuronal migration ([@bib41]). These data indicate that a disturbance in MT dynamics and/or organization caused by the loss of MAPs results in an abnormal motility of migrating neurons. In the present study, we characterized the phenotypes of MAP2- and MAP1B-deficient mice and conclude that these proteins are synergistically involved in neuronal cell migration.

Based on our neuronal birth-dating analysis, *map2* ^−/^− *map1b* ^−/^− mouse cortical neurons exhibited migration defects without an inverted (outside-in) laminar formation pattern that was reported in *reeler* and related mutant mice ([@bib30]; [@bib37]; [@bib45]). This difference in migratory defects suggests a pathophysiological mechanism in *map2* ^−/^−*map1b* ^−/^− mice that is distinct from that of in *reeler* mice. One possible explanation is that the loss of regulation by Cdk5/P35 is responsible for the perturbed neuronal migration because the Cdk5/P35 complex may regulate the affinity of MAP2 and MAP1B to MTs by phosphorylation ([@bib29]; [@bib33]), and knockout mice lacking either *cdk*5 or *p*35 have represented mice with disrupted cortical layering ([@bib28]; [@bib5]). However, this explanation is not adequate because the cortical layering in these mice has an outside-in order, which differs from that observed in *map2* ^−/^−*map1b* ^−/^− mice. We consider that there are multiple molecular mechanisms in the histogenesis of cortical layers and that MAP2 and MAP1B are involved in a pathway different from the Reelin or Cdk5/P35 pathway.

Organization of growth cone microtubules
----------------------------------------

The growth cone is a key structure for generating new neurites in which the MT organization is changed sequentially ([@bib43]). In brief, the growth cones can be divided into the following three stages: (a) MTs are dispersed and splayed throughout the growth cone; (b) MTs are looped, contorted, and compressed; and (c) MTs are bundled into tight arrays ([@bib42]). In the growth cones from *map2* ^−/^−*map1b* ^−/^− mouse neurons, the frequency of stages 1 and 2 is increased significantly. This suggests that stage 3 was impaired selectively in these neurons due to the loss of MAP2 and MAP1B activities cross-linking MTs. We consider that MTs in *map2* ^−/^− *map1b* ^−/^− mouse growth cones take longer time to form tight arrays, resulting in the increased dispersed and looped MT formations, which could lead to reduced growth cone motility ([@bib46]; [@bib17]).

On the other hand, neuronal cell migration is also guided by growth cones situated at the tip of leading processes as in neuritic elongation ([@bib31]). A similar pathology of MT disorganization could also exist in the growth cones of migrating neurons.

MT spacing in neuritic shafts
-----------------------------

MAPs are known to form cross-bridge structures between MTs ([@bib20]). A previous study using Sf9 cells indicated that the difference in NH~2~-terminal projection domains between Tau and MAP2 could determine the length of cross-bridge structures between MTs; therefore, the different organizations of MT domains characterize axons and dendrites ([@bib6]). However, there has been no in vivo evidence supporting the significance of MAPs in determining MT spacing. In this study, we present for the first time genetic data showing that the lack of MAPs results in altered MT spacing. Moreover, we investigated a possible change in fast transport due to the altered MT organization by visualizing transported vesicles in living cells. However, the vesicle transport was intact in *map2* ^−/^−*map1b* ^−/^− mouse neurons. Taken together, we consider that the most influential factor that causes these morphological defects is the disorganization of growth cone MTs, which could lead to reduced growth cone motility, leading in turn to the abnormal shape of neurons.

Future directions
-----------------

A large number of gene-targeting studies have revealed that neurons use their molecular machinery in a redundant manner. In the present study, we found novel aspects of MAP2 and MAP1B function by comparative analysis between double knockout mice and their corresponding single knockout mice. Such an approach will be useful in elucidating cooperative interactions of proteins in vivo.

Materials and methods
=====================

Maintenance of mice
-------------------

Mice were maintained on a 12-h light/12-h dark schedule in a specific pathogen-free environment. Females and males were crossed in a timed mating schedule (from 11:00 to 14:00). Conception was ascertained by the presence of a vaginal plug. Plug check was conducted at 14:00. The day of conception was considered as E0. E19 was referred to as P0 regardless of the occurrence or nonoccurrence of birth. Mice were maintained by repeated backcrossing to C57BL/6J mice and analyzed in a C57BL/6J (84.4--98.1%)/129/Sv (15.6--1.9%) background. The genotype was determined by PCR analysis and confirmed by Southern blotting ([@bib40]).

SDS-PAGE and immunoblot
-----------------------

Crude extracts from whole brains were prepared as described previously ([@bib40]). After gel electrophoresis, proteins were transferred onto an Immobilon TM membrane (Millipore), and they were probed with 3d2 antibody for anti-MAP1B ([@bib27]) and with HM-2 (Sigma-Aldrich) and AP-14, -18, -20, -21, -23, and -25 ([@bib22]) antibodies for anti-MAP2. Peroxidase-conjugated anti--mouse IgG antibody (Cappel Labs) was used as a secondary antibody. Chromogenic reaction was carried out using 4-chlorol-1-naphthol.

Histopathology
--------------

The brains of mice at P0 were dissected out and fixed with FEA overnight. The tissues were dehydrated in ethanol, embedded in Paraplast (Oxford Labware), sectioned serially at 12 Ìm thickness using Microm (HM355; Rotary Micotome) and stained by the Bodian method, a silver staining procedure for visualizing nerve fibers ([@bib41]).

Whole-mount immunohistochemistry
--------------------------------

Embryos were fixed with 4% paraformaldehyde in 0.1 M phosphate buffer (pH 7.3). Activities of endogenous peroxidases were quenched by 2% hydrogen peroxide in Dent\'s fixative (1 part DMSO, 4 parts 100% methanol). The neurofilament antibody 2H3 (Developmental Studies Hybridoma Bank) was used as the first antibody. As the secondary antibody, HRP-conjugated goat anti--rabbit IgG (Jackson ImmunoResearch Laboratories) was used. The secondary antibody was detected with 0.5% diaminobenzidine plus 0.02% hydrogen peroxide. In this experiment ([Fig. 4](#fig4){ref-type="fig"}), we regard *map2* ^+/^ *map1b* ^+/^ as the control, *map2* ^−/^−*map1b* ^+/^ as *map2* single mutant, and *map2* ^+/^ *map1b* ^−/^− as *map1b* single mutant mice to achieve efficient sample collection and compare the same developmental stage of embryos among littermates.

Neuronal birth-dating analysis
------------------------------

Experiments were performed as described previously ([@bib39]). Pregnant mice at E12 and E14 were intraperitoneally given a single injection of BrdU (5-bromo-2′-deoxyuridine) (5 mg/ml in saline solution which contained 0.007 N sodium hydroxide; Sigma-Aldrich) at a dose of 50 Ìg/g body weight. At E18, the brains of embryos were examined. The sections were counterstained with Nuclear Fast red (Vector Laboratories).

For quantitative measurements of BrdU-labeled nuclei, comparable sections were chosen at the level of anterior commissure, which was divided into 10 horizontal bins from the superficial to the deep, and labeled nuclei in each bin were counted. In each genotype, at least three mice were examined.

Immunostaining of cryostat sections
-----------------------------------

Brains of embryos were dissected out and fixed with 2% paraformaldehyde in 0.1 M PBS (pH 7.4) for 2 h at room temperature. Cryostat coronal sections of cerebral walls (16 or 20 Ìm) were prepared using a cryomicrotome (CM3000; Leica) mounted on APS-coated microscope slides and air dried. As primary monoclonal antibodies, RC2 supernatant (Developmental Studies Hybridoma Bank), antichondroitin sulfate proteoglycan (CSPG) (clone CS56; Sigma-Aldrich), and anti-Reelin CR-50 antibodies (provided by Dr. Kazunori Nakajima, Jikei University) ([@bib49]) were used.

Hippocampal cell culture and immunofluorescence microscopy
----------------------------------------------------------

Cultures of hippocampal neurons were prepared as described previously ([@bib16]). In this experiment ([Fig. 6](#fig6){ref-type="fig"}), we intercrossed *map2* ^+/^−*map1b* ^+/^− and *map2* ^−/^−*map1b* ^+/^− mice and compared neurons derived from *map2* ^+/^−*map1b* ^+/^, *map2* ^−/^−*map1b* ^+/^, *map2* ^+/^ *map1b* ^−/^−, and *map2* ^−/^−*map1b* ^−/^− littermate mice to collect samples efficiently. The cultures were photographed directly using an inverted phase--contrast microscope (Nikon) and observed with a conventional fluorescence microscope AX (Olympus) or a confocal laser scanning microscope (LSM510; ZEISS or MRC-1000; Bio-Rad Laboratories) after immunostaining. The lengths of axons and dendrites were measured in three independent experiments.

Immunocytochemistry was performed as described previously ([@bib41]). A monoclonal antityrosine tubulin TUB-1A2 antibody (Sigma-Aldrich) and a polyclonal anti-GluR1 IgG (Chemicon) were used as the primary antibodies. For actin staining, FITC-conjugated phalloidin (Sigma-Aldrich) was used.

Rescue experiment on cultured hippocampal neurons
-------------------------------------------------

The full-length cDNA of rat MAP2C ([@bib6]) was tagged with EGFP (CLONTECH Laboratories, Inc.) at the NH~2~ termini and ligated into pAdexCAw1 vector with CAG promoter to produce the recombinant adenovirus as described previously ([@bib26]). Cultured hippocampal neurons (prepared as described above except for the deletion of coculture with glia and supplementation with B27 supplement; GIBCO BRL) were infected by the adenovirus on the day of plating and observed after 3 d.

Electron microscopy
-------------------

Mice and cultured hippocampal cells were fixed with 2% paraformaldehyde and 2.5% glutaraldehyde in 0.1 M sodium cacodylate buffer (pH 7.4). Brains were dissected out and sectioned using a microslicer. Matching areas of each tissue were chosen, fixed overnight, processed by the conventional method, and observed with a transmission electron microscope (JEOL-2000 EX or 2010 H). Distances between the nearest adjacent MTs in the axon and dendrites of each genotype were measured directly and counted, respectively, from prints. For each genotype, at least two independent mice were examined.

Time-lapse analysis of vesicle transport
----------------------------------------

The recombinant adenovirus expressing a GFP-tagged GAP-43 ([@bib26]) were infected into 17-d-old cultured hippocampal cells over a period of 20 min. The cells were examined 36 h after infection using the MRC1024 confocal laser scanning unit (Bio-Rad Laboratories) at room temperature. The axons were excited using a krypton-argon laser at 488 nm wavelength. Following the method previously described ([@bib26]), the axons were first bleached by continuous scanning for ∼1 min with 100% laser power at zoom 6.0 and then observed under 30 or 10% laser power at zoom 4.0. The speed of the vesicles was determined by measuring the distance the vesicles moved between two successive frames (5 s).
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